Dose response of continuous subcutaneous infusion of recombinant glucagon‐like peptide‐1 in combination with metformin and sulphonylurea over 12 weeks in patients with type 2 diabetes mellitus
Year: 2013
Type: article
Source: Diabetes Obesity and Metabolism
DOI: 10.1111/dom.12240
Authors: S. S. Torekov, J. J. Holst, M. R. Ehlers
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2034062059
